Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Expert Opinion on Investigational Drugs|December 12, 2024
Survodutide in MASH: bridging the gap between hepatic and systemic metabolic dysfunctionEda Kaya, Yusuf Yilmaz, Naim AlkhouriCurrent Opinion in Gastroenterology|February 25, 2025
Glucagon like peptide-1 receptor agonists as a promising therapeutic option of metabolic dysfunction associated steatotic liver disease and obesity: hitting two targets with one shotEda Kaya, Wing-Kin Syn, Paul MankaJournal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|October 13, 2019
Histopathologic and Immunohistochemical Investigation of the Effects of Vitamin C on Bone Healing in Rats Exposed to NicotineEda Kaya Akça, Berkem Atalay, Bilgin ÖnerHepatology Forum|August 11, 2022
The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminasesEda Kaya, Alev Bakir, Fatih Eren, et al.Hepatology Forum|January 22, 2026
Microplastics and nanoplastics: Emerging drivers of liver damage and metabolic dysfunctionYusuf Yilmaz, Cem Simsek, Mete Ucdal, et al.Clinical Transplantation|July 8, 2018
Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean feverSinan Trabulus, Merve Korkmaz, Eda Kaya, et al.European Journal of Gastroenterology & Hepatology|February 25, 2020
Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patientsPinar Hamurcu Varol, Eda Kaya, Emel Alphan, et al.Annals of Hepatology|March 28, 2025
Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver diseaseEda Kaya, Eduardo Vilar-Gomez, Raj Vuppalanchi, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|December 12, 2019
Characterization of Patients with Biopsy-Proven Non-Alcoholic Fatty Liver Disease and Normal Aminotransferase LevelsCelal Ulasoglu, Feruze Yilmaz Enc, Eda Kaya, et al.Hepatology Forum|July 5, 2022
Prevention of hepatocellular carcinoma and monitoring of high-risk patientsEda Kaya, Guillermo Daniel Mazzolini, Yusuf Yilmaz, et al.Pageof 5